198 related articles for article (PubMed ID: 12411451)
1. Angiotensin blockade prevents type 2 diabetes by formation of fat cells.
Sharma AM; Janke J; Gorzelniak K; Engeli S; Luft FC
Hypertension; 2002 Nov; 40(5):609-11. PubMed ID: 12411451
[TBL] [Abstract][Full Text] [Related]
2. The obese patient with diabetes mellitus: from research targets to treatment options.
Sharma AM
Am J Med; 2006 May; 119(5 Suppl 1):S17-23. PubMed ID: 16563943
[TBL] [Abstract][Full Text] [Related]
3. Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 2. Overview of physiological and biochemical mechanisms.
Scheen AJ
Diabetes Metab; 2004 Dec; 30(6):498-505. PubMed ID: 15671919
[TBL] [Abstract][Full Text] [Related]
4. Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.
Scheen AJ
Drugs; 2004; 64(22):2537-65. PubMed ID: 15516153
[TBL] [Abstract][Full Text] [Related]
5. Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors.
Janke J; Engeli S; Gorzelniak K; Luft FC; Sharma AM
Diabetes; 2002 Jun; 51(6):1699-707. PubMed ID: 12031955
[TBL] [Abstract][Full Text] [Related]
6. Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin-angiotensin system.
Kurtz TW; Pravenec M
J Hypertens; 2004 Dec; 22(12):2253-61. PubMed ID: 15614015
[TBL] [Abstract][Full Text] [Related]
7. Acute regulation of pancreatic islet microcirculation and glycaemia by telmisartan and ramipril: discordant effects between normal and type 2 diabetic rats.
Olverling A; Huang Z; Nyström T; Sjöholm Å
Clin Sci (Lond); 2013 Nov; 125(9):433-8. PubMed ID: 23713675
[TBL] [Abstract][Full Text] [Related]
8. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
Leiter LA; Lewanczuk RZ
Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II receptor blocker telmisartan prevents new-onset diabetes in pre-diabetes OLETF rats on a high-fat diet: evidence of anti-diabetes action.
Zhao ZQ; Luo R; Li LY; Tian FS; Zheng XL; Xiong HL; Sun LT
Can J Diabetes; 2013 Jun; 37(3):156-68. PubMed ID: 24070838
[TBL] [Abstract][Full Text] [Related]
10. Telmisartan, an angiotensin II type 1 receptor blocker, prevents the development of diabetes in male Spontaneously Diabetic Torii rats.
Hasegawa G; Fukui M; Hosoda H; Asano M; Harusato I; Tanaka M; Shiraishi E; Senmaru T; Sakabe K; Yamasaki M; Kitawaki J; Fujinami A; Ohta M; Obayashi H; Nakamura N
Eur J Pharmacol; 2009 Mar; 605(1-3):164-9. PubMed ID: 19171132
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II receptor blockers downsize adipocytes in spontaneously type 2 diabetic rats with visceral fat obesity.
Mori Y; Itoh Y; Tajima N
Am J Hypertens; 2007 Apr; 20(4):431-6. PubMed ID: 17386352
[TBL] [Abstract][Full Text] [Related]
12. An angiotensin II AT1 receptor antagonist, telmisartan augments glucose uptake and GLUT4 protein expression in 3T3-L1 adipocytes.
Fujimoto M; Masuzaki H; Tanaka T; Yasue S; Tomita T; Okazawa K; Fujikura J; Chusho H; Ebihara K; Hayashi T; Hosoda K; Nakao K
FEBS Lett; 2004 Oct; 576(3):492-7. PubMed ID: 15498586
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin inhibition stimulates PPARgamma and the release of visfatin.
Storka A; Vojtassakova E; Mueller M; Kapiotis S; Haider DG; Jungbauer A; Wolzt M
Eur J Clin Invest; 2008 Nov; 38(11):820-6. PubMed ID: 19021699
[TBL] [Abstract][Full Text] [Related]
14. The renin-angiotensin-aldosterone system: a pivotal role in insulin sensitivity and glycemic control.
Perkins JM; Davis SN
Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):147-52. PubMed ID: 18316950
[TBL] [Abstract][Full Text] [Related]
15. Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property.
Yamagishi S; Takeuchi M
Med Hypotheses; 2005; 64(3):476-8. PubMed ID: 15617852
[TBL] [Abstract][Full Text] [Related]
16. PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin.
Clasen R; Schupp M; Foryst-Ludwig A; Sprang C; Clemenz M; Krikov M; Thöne-Reineke C; Unger T; Kintscher U
Hypertension; 2005 Jul; 46(1):137-43. PubMed ID: 15939809
[TBL] [Abstract][Full Text] [Related]
17. Role of renin-angiotensin-aldosterone system in adipose tissue dysfunction.
Jing F; Mogi M; Horiuchi M
Mol Cell Endocrinol; 2013 Sep; 378(1-2):23-8. PubMed ID: 22465098
[TBL] [Abstract][Full Text] [Related]
18. Renin angiotensin system inhibition attenuates adipocyte-breast cancer cell interactions.
Rasha F; Ramalingam L; Menikdiwela K; Hernandez A; Moussa H; Gollahon L; Layeequr Rahman R; Moustaid-Moussa N
Exp Cell Res; 2020 Sep; 394(1):112114. PubMed ID: 32504676
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the pancreatic renin-angiotensin system in insulin resistance and the metabolic syndrome.
Leung PS; de Gasparo M
J Cardiometab Syndr; 2006; 1(3):197-203. PubMed ID: 17679833
[TBL] [Abstract][Full Text] [Related]
20. Renin-angiotensin system and cardiovascular risk.
Schmieder RE; Hilgers KF; Schlaich MP; Schmidt BM
Lancet; 2007 Apr; 369(9568):1208-19. PubMed ID: 17416265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
